Table 2.
Distribution of the antidepressant medications in patients.
| Antidepressant | n (%) | Dosage Range (Min-Max) |
|---|---|---|
| SSRI | ||
| Escitalopram/cipralex | 7 (7.9) | 10–20 mg/day |
| Citalopram | 9 (10.1) | 10–40 mg/day |
| Sertraline | 13 (14.6) | 50–150 mg/day |
| Elontrile/bupropion | 6 (6.7) | 100–300 mg/day |
| Fluoxetine | 2 (2.2.) | 25–30 mg/day |
| Trazodone | 1 (1.1.) | 100 mg/day |
| SNRI | ||
| Venlaflaxine/trevilor | 15 (16.9) | 50–375 mg/day |
| Milnacipran/milnaneurax | 2 (2.2) | 12.5–25 mg/day |
| Duloxetine/cymbalta | 4 (4.5) | 90–120 mg/day |
| Tetracyclic antidepressants | ||
| Mirtazapine | 13 (14.6) | 6.5–30 mg/day |
| Tricyclic antidepressant | ||
| Trimipramine/trimineurine | 9 (10.1) | 25–100 mg/day |
| Opipramole | 1 (1.1) | 300 mg/day |
| Amitriptyline/amitrile | 2 (2.2) | 25–75 mg/day |
| Doxepin | 2 (2.2) | 50–150 mg |
| Melatonin receptor agnonist | ||
| Valdoxan | 6 (6.7) | 25–50 mg |
| Total number of patients receiving antidepressants | 69 (77.5) |